Browsing: Windlas Biotech
4 weeks ago
Windlas Biotech Q2 Results: EBITDA Margin Shows Slight Improvement
- Indian Markets
- Block Deals
- Commodities
- Earnings Reports
- Global Insights
- Investing
- Bonds
- Market Analysis
- Special coverage
Recent Posts
- OPEC+ Demonstrates Flexibility Amidst Market Uncertainty
- Laurus Labs Secures ₹1.2 Billion Investment from Eight Roads Ventures and F-Prime Capital, Retains 74.64% Stake
- FII Selling Outweighed by DII Buying in Indian Market
- India’s November Fuel Sales Rise 9.33% YoY to 20.43 Million Metric Tons: Government
- Intellect Design Arena: Leadership Transition and Winding Up of AIF